Immunic
Tracked across 5 events · 40 articles · First seen Apr 01, 2026 · Last active Sep 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Immunic will participate in several investor, industry, and scientific conferences in June 2026 to present its pipeline and engage with investors and partners, potentially increasing its visibility and attracting investment.
Jun 10, 2026 · 10 articles
Business
Impact: Immunic is the company announcing its participation in investor conferences, which is a standard practice to engage with investors and analysts.
Jul 09, 2026 · 8 articles
Business
Impact: Immunic is the central entity, appointing a new board member to strengthen its leadership as it approaches pivotal Phase 3 data and potential commercialization.
Aug 10, 2026 · 6 articles
Business
Impact: Immunic is the central entity, appointing a new executive to strengthen its data and digital capabilities ahead of potential regulatory filing and commercialization. This move is part of its preparation for Phase 3 data readouts and NDA submission.
Sep 01, 2026 · 8 articles
Business
Impact: Immunic is the host of the R&D day and the developer of vidofludimus calcium. The event is part of its investor relations efforts ahead of Phase 3 data readout.
Sep 02, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Immunic live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard